- Report
- February 2024
- 96 Pages
Global
From €3500EUR$3,899USD£3,108GBP
- Report
- August 2021
- 94 Pages
Global
From €3200EUR$3,565USD£2,841GBP
- Report
- November 2020
- 110 Pages
Global
From €4327EUR$4,500USD£3,712GBP
- Report
- August 2021
- 310 Pages
Global
From €5931EUR$6,168USD£5,088GBP
- Report
- August 2021
- 159 Pages
Asia Pacific
From €3931EUR$4,088USD£3,372GBP
- Report
- April 2021
- 206 Pages
Global
From €5931EUR$6,168USD£5,088GBP
- Report
- April 2021
- 142 Pages
Global
From €5931EUR$6,168USD£5,088GBP
- Report
- January 2022
- 141 Pages
France
From €5931EUR$6,168USD£5,088GBP
- Report
- September 2023
- 160 Pages
Global
From €2884EUR$2,999USD£2,474GBP
- Report
- May 2023
- 160 Pages
Global
From €5768EUR$5,999USD£4,948GBP
- Report
- May 2023
- 140 Pages
Global
From €5768EUR$5,999USD£4,948GBP
Artificial Insemination (AI) is a medical procedure used to assist women in achieving pregnancy. It involves the introduction of sperm into the female reproductive tract, either through the cervix or directly into the uterus. AI is often used when a woman is unable to conceive naturally due to infertility, or when a couple wishes to use donor sperm. AI can also be used to increase the chances of conception in women with ovulatory disorders. AI is a safe and effective method of assisted reproduction, and is often used in combination with other fertility treatments.
AI is an important part of women's health, as it can help women who are unable to conceive naturally to become pregnant. AI can also provide couples with the opportunity to have a child that is genetically related to one or both partners.
Companies in the AI market include Cook Medical, CooperSurgical, Vitrolife, and Genea Biomedx. Show Less Read more